i-CHIRAL 4 can be successfully used by researchers as a primary screening tool for target chiral compounds.
West Chester, PA (PRWEB) November 14, 2013
Chiral Technologies announced today the availability of i-CHIRAL 4, a set of four Daicel 3-µm immobilized CSPs – CHIRALPAK® IA, IB, IC and ID – packed in columns of 4.6 mm internal diameter and 150 mm long. This combination of columns will raise method development success rate to greater than 89 percent, calculated from screening over 100 chiral compounds with a single mobile phase.
“i-CHIRAL 4 can be successfully used by researchers as a primary screening tool for target chiral compounds,” said Mark McDonald, Vice President, Sales and Marketing for Chiral Technologies. “The tool set will greatly reduce screening time, boosting laboratory productivity and maximizing funding from research budgets.”
i-CHIRAL 4 is designed for high-speed, high-efficiency separations of enantiomers. The immobilized CSPs exhibit greatly enhanced robustness and remarkable stability, allowing separation scientists to employ essentially any organic solvent as mobile phase to handle the most challenging of separations.
About Chiral Technologies
Chiral Technologies, the global leader in enantioselective chromatography, serves pharmaceutical and other life science industries and offers the largest portfolio of chiral stationary phases (CSPs) and analytical and preparative chiral columns for the separation of racemic mixtures into single enantiomers. The company also provides analytical method development and custom separation services. The North and Latin American markets are served through Chiral Technologies Inc. (West Chester, Pa.), the European market through Chiral Technologies Europe SAS (Illkirch, France), and the Asian market through Daicel Chiral Technologies India and Daicel Chiral Technologies China, all wholly owned subsidiaries of Daicel Corporation. Learn more at http://www.chiraltech.com, http://www.chiral.fr, and http://www.daicelchiraltech.cn.